Cargando…
Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact
Prognosis of hepatocellular carcinoma (HCC) could be affected by lack of or delayed therapy. We aimed to characterize the prevalence, correlates, and clinical impact of therapeutic underuse and delay in patients with HCC. Patients with HCC diagnosed between 2010 and 2017 were analyzed from the Unite...
Autores principales: | Govalan, Rajalakshmi, Luu, Michael, Lauzon, Marie, Kosari, Kambiz, Ahn, Joseph C., Rich, Nicole E, Nissen, Nicholas, Roberts, Lewis R., Singal, Amit G., Yang, Ju Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710787/ https://www.ncbi.nlm.nih.gov/pubmed/34558830 http://dx.doi.org/10.1002/hep4.1795 |
Ejemplares similares
-
Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma
por: Pandyarajan, Vijay, et al.
Publicado: (2021) -
Approach to systemic therapy in advanced hepatocellular carcinoma
por: Sankar, Kamya, et al.
Publicado: (2022) -
Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response
por: Osho, Azeez, et al.
Publicado: (2020) -
Pulsus paradoxus: an underused tool
por: Bandinelli, G., et al.
Publicado: (2007) -
Underuse of Surveillance Colonoscopy in Patients at Increased Risk of Colorectal Cancer
por: Murphy, Caitlin C, et al.
Publicado: (2015)